“Efficacy of Ritlecitinib (PF-06651600) in Patients With Alopecia Totalis and Alopecia Universalis: Post Hoc Analysis of the ALLEGRO Phase 2b 3 Study”. 2022. SKIN The Journal of Cutaneous Medicine 6 (6): s102. https://doi.org/10.25251/skin.6.supp.102.